Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Short term Debt (2016 - 2025)

Conmed (CNMD) has disclosed Short term Debt for 16 consecutive years, with $712000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Short term Debt changed 0.42% year-over-year to $712000.0, compared with a TTM value of $712000.0 through Dec 2025, changed 0.42%, and an annual FY2025 reading of $712000.0, changed 0.42% over the prior year.
  • Short term Debt was $712000.0 for Q4 2025 at Conmed, down from $746000.0 in the prior quarter.
  • Across five years, Short term Debt topped out at $70.6 million in Q3 2023 and bottomed at $237000.0 in Q3 2022.
  • Average Short term Debt over 5 years is $18.3 million, with a median of $731500.0 recorded in 2024.
  • The sharpest move saw Short term Debt skyrocketed 29699.58% in 2023, then plummeted 99.01% in 2024.
  • Year by year, Short term Debt stood at $12.2 million in 2021, then soared by 469.4% to $69.7 million in 2022, then plummeted by 98.98% to $708000.0 in 2023, then increased by 0.99% to $715000.0 in 2024, then decreased by 0.42% to $712000.0 in 2025.
  • Business Quant data shows Short term Debt for CNMD at $712000.0 in Q4 2025, $746000.0 in Q3 2025, and $714000.0 in Q2 2025.